ArticleJournal of personalized medicine2021

Risk Reclassification of Patients with Endometrial Cancer Based on Tumor Molecular Profiling: First Real World Data.

Felicitas Oberndorfer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.